Ambitious Priorities: Breaking Down FDA’s FY27 Budget

As the Fiscal Year 2027 (FY27) budget and appropriations process kicks into full swing this month, the release of the President’s budget and related congressional hearings provide opportunities to gain insight into both the Trump administration’s and congressional lawmakers’ areas of focus for the Department of Health and Human Services, including the Food and Drug Administration (FDA). How FDA is implementing its mission to protect and promote...... By: Akin Gump Strauss Hauer & Feld LLP